Lupin divests Japanese subsidiary Kyowa Criticare to Neopharma group
Mumbai , Aug 22 : Pharma major Lupin Ltd said on Thursday that it has entered into a definitive agreement for the sale of its Japanese injectables business and related assets to Neo Ala Co Ltd, a wholly-owned subsidiary of Neopharma Group which is the UAE's largest pharmaceutical manufacturer headquartered in Abu Dhabi.
GSK Pharma profit jumps to Rs 113 crore in Q1 FY20
Mumbai , July 22 : GlaxoSmithKline (GSK) Pharmaceuticals on Monday announced 35 per cent jump in its net profit to Rs 113.5 crore during the first quarter of current fiscal from Rs 88.6 crore in the corresponding quarter ended June 30 last year.
Indoco's Goa plant gets warning letter from USFDA
Mumbai , July 15 : Pharma company Indoco Remedies said on Monday it has received a warning letter from the United States Food and Drug Administration (USFDA) for its oral dosages plant in Goa as a result of the inspection carried out in January.
GSK Pharma, RCB launch 'Trust in Science Programme'
New Delhi, June 26 : Pharma major GSK Pharmaceuticals and government's Regional Centre for Biotechnology (RCB) on Wednesday launched a joint initiative -- Trust in Science Programme -- to develop doctoral programs in the fields of biostatistics and bioinformatics.
Narayana Hrudayalaya reports 32 pc jump in EBITDA for FY 19
Bengaluru , May 25 : Leading healthcare service provider Narayana Hrudayalaya has said its consolidated total operating income stood at Rs 2,861 crore during 2018-19, up 25 per cent as compared to Rs 2,281 crore in the corresponding period of previous year.
West NovaGuard SA Pro safety system recognized at India Packaging Awards
Mumbai May 22 : West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, is pleased to announce that the NovaGuard SA Pro safety system - a single-use accessory for prefilled ISO standard 1mL long Staked-needle syringes - has won the India Packaging Awards for Excellence in Enhanced User Experience and Excellence in Packaging Design - Shapes and Structures.
Reddit posts reveal opioid addiction treatment risks
New York, May 3 : Using advanced Machine Learning (ML) techniques on nearly 1.5 million Reddit posts, researchers, including one of Indian origin, have identifed risks associated with self-treatment for opioid addiction.
Nationwide campaign launched for angina awareness
Mumbai April 25 : SERDIA Pharmaceuticals (INDIA) Pvt Ltd, a leader in cardiology, conducted a nation-wide campaign to raise awareness on angina. The campaign urged people to not ignore symptoms of angina-like clutching pain, heaviness or tightness in chest, pain in neck/shoulder, fatigue, backache and breathlessness and to consult a doctor at an early stage. The field force also reached out to thousands of doctors through their in-clinics awareness drive.
Dr Reddy's re-launch generic version of Suboxone in US
Hyderabad, Feb 20 : With US Supreme Court ruling in its favour, Indian pharma major Dr. Reddy's Laboratories on Wednesday announced re-launch of generic version of Suboxone, a sublingual film for opioid addition treatment, in the US market.
Dr Reddy's Q3 net up by 45pc YoY
Hyderabad, Feb 1 : Pharma major Dr Reddy's on Friday reported a rise of 45 per cent in its consolidated net profit for the third quarter of 2018-19, at Rs 485 crore from Rs 334 crore during the corresponding period of the previous fiscal.
Sun Pharma stock rebounds, jumps 4pc
Mumbai, Jan 21 : Pharmaceutical major Sun Pharma's stock gained 4 per cent to touch a high of Rs 406.35 on Monday after it ended Friday's trade lower at more than 8 per cent.
Sun Pharma stocks plunge on revelation of whistleblower's complaint
Mumbai, Jan 18 : The stock of pharmaceutical major Sun Pharma ended up as the top loser on the BSE Sensex on Friday following reports of a complaint by a whistleblower to the Securities and Exchange Board of India (Sebi) against the company, raising issues of corporate governance.
Torrent Pharma recalls Losartan hypertension tablet in US
Chennai, Dec 21 : Indian pharmaceutical major Torrent Pharmaceuticals Ltd is voluntarily recalling two lots of Losartan potassium tablets -- used to treat hypertension -- in the US market due to detection of traces of unexpected impurity, the US Food and Drug Administration (USFDA) said.
Health Ministry bans use of 328 FDCs
New Delhi , Sep 14 : The Ministry of Health and Family Welfare has banned the manufacture for sale, sale or distribution for human use of 328 Fixed Dose Combinations (FDCs).
Counter antibiotics with priobiotics
Washington DC, Sep 15 : A recent study has highlighted that the use of probiotics is directly linked to the reduced need for antibiotic treatment in infants and children.
Saridon, Panderm among over 6,000 medicines face ban
New Delhi, Sep 13 : The Centre's decision on Wednesday to ban the manufacture, sale and distribution of 328 Fixed Dose Combination (FDC) drugs has brought around 6,000 prominent medicines under the radar, including some very commonly used ones.
Lupin Q1 profit falls 43pc to Rs 203 cr
Mumbai, Aug 8 : Pharma major Lupin Limited on Wednesday reported a 43.4 per cent fall in its consolidated net profit at Rs 202.8 crore for the quarter ended June 30.
Pharma companies must invest in R and D to keep growing: Prabhu
New Delhi, July 13 : Noting that India is now recognized globally as a key player in the generic medicine industry, Commerce Minister Suresh Prabhu on Friday asked pharmaceutical companies to invest in research and development (R and D) for further growth of the sector.